These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 440228)

  • 21. Experience with pion radiotherapy.
    Kligerman MM; von Essen CF; Khan MK; Smith AR; Sternhagen CJ; Sala JM
    Cancer; 1979 Mar; 43(3):1043-51. PubMed ID: 371782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PIOTRON: initial performance, preparation and experience with pion therapy.
    von Essen CF; Blattmann H; Crawford JF; Fessenden P; Pedroni E; Perret C; Salzmann M; Shortt K; Walder E
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1499-509. PubMed ID: 6815138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple scattering distributions for therapeutic pion beams.
    Amols HI; Büche G; Kluge W; Matthäy H; Moline A; Münchmeyer D
    Phys Med Biol; 1981 Mar; 26(2):277-89. PubMed ID: 7220604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical studies of dynamic treatment modes in pion therapy.
    Amols HI; Kittell R; Paciotti MA; Hellend JA; Hogstrom KR; Collier M; Heller P
    Med Phys; 1980; 7(6):621-6. PubMed ID: 7464705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential for therapeutic gain similar to pions by daily combinations of neutrons and low-LET radiations.
    Kligerman MM
    Med Hypotheses; 1979 Feb; 5(2):257-64. PubMed ID: 459978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of beam characteristics and detector size in negative-pion dose studies.
    Hamm RN; Wright HA; Turner JE
    Phys Med Biol; 1979 May; 24(3):613-20. PubMed ID: 461520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the use of the pion stopping distribution and the lesion additivity concept for the calculation of effective doses in pion treatment planning.
    Lam GK
    Phys Med Biol; 1990 Jun; 35(6):731-40. PubMed ID: 2114647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pions for radiotherapy at TRIUMF.
    Skarsgard LD; Henkelman RM; Eaves CJ
    J Can Assoc Radiol; 1980 Mar; 31(1):3-12. PubMed ID: 7364844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The multi-disciplinary role of 'pion factories'.
    Davies JD; Batty CJ; Green K
    Nature; 1977 Dec 22-29; 270(5639):667-71. PubMed ID: 593390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy planning and dosimetry for the pion applicator at the Swiss Institute for Nuclear Research (SIN).
    Blattmann H
    Radiat Environ Biophys; 1979 Aug; 16(3):205-9. PubMed ID: 116304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo studies of the TRIUMF pion therapy beam.
    Skarsgard LD; Douglas BG; Denekamp J; Chaplin DJ; Lam GK; Harrison RW; Kornelsen RO; Palcic B
    Radiat Res Suppl; 1985; 8():S135-44. PubMed ID: 3937169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A model for calculating the effects of small inhomogeneities on electron beam dose distributions.
    Perry DJ; Holt JG
    Med Phys; 1980; 7(3):207-15. PubMed ID: 7393146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muon dose distribution from a decaying pencil beam of pions.
    Brosing JW; Henkelman RM
    Phys Med Biol; 1981 Jul; 26(4):633-40. PubMed ID: 6789343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment planning for negative pi-meson radiation therapy: simultaneous multi-port irradiation with the Stanford Medical Pion Generator (SMPG).
    Pistenma DA; Li GC; Fessenden P; White K; Bagshaw MA
    Int J Radiat Oncol Biol Phys; 1977; 3():315-23. PubMed ID: 96067
    [No Abstract]   [Full Text] [Related]  

  • 35. A lyoluminescent tissue-equivalent dosemeter for pion therapy beams.
    Atari NA; Malik SR; Brenner DJ; Hilko R; Bradbury JN
    Phys Med Biol; 1983 May; 28(5):493-502. PubMed ID: 6408655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pion radiotherapy at LAMPF.
    Bush SE; Smith AR; Zink S
    Int J Radiat Oncol Biol Phys; 1982 Dec; 8(12):2181-6. PubMed ID: 6298158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomedical program leading to therapeutic trials on pion radiation at Los Alamos.
    Kligerman MM; Knapp EA; Petersen DF
    Cancer; 1975 Nov; 36(5):1675-80. PubMed ID: 1192358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of a negative pion beam for the irradiation of superifical nodules in cancer patients.
    Richman C
    Radiat Res; 1976 Jun; 66(3):453-71. PubMed ID: 819958
    [No Abstract]   [Full Text] [Related]  

  • 39. Microdosimetry of negative poins at LAMPF.
    Amols HI; Dicello JF; Lane TF; Pfeufer GW; Helland JA; Knowles HB
    Radiology; 1975 Jul; 116(1):183-5. PubMed ID: 806097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electron dose calculation using multiple-scattering theory: thin planar inhomogeneities.
    Jette D; Lanzl LH; Pagnamenta A; Rozenfeld M; Bernard D; Kao M; Sabbas AM
    Med Phys; 1989; 16(5):712-25. PubMed ID: 2509866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.